GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 58 filers reported holding GEMINI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,006,000 | -1.9% | 613,214 | +1.1% | 0.00% | – |
| Q2 2022 | $1,025,000 | +104.6% | 606,368 | +68.0% | 0.00% | – |
| Q1 2022 | $501,000 | -56.0% | 360,910 | -7.8% | 0.00% | – |
| Q4 2021 | $1,139,000 | -30.9% | 391,256 | -4.1% | 0.00% | – |
| Q3 2021 | $1,648,000 | -46.7% | 407,963 | -14.6% | 0.00% | -100.0% |
| Q2 2021 | $3,090,000 | -47.8% | 477,534 | +9.3% | 0.00% | 0.0% |
| Q1 2021 | $5,922,000 | – | 437,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Running Point Capital Advisors, LLC | 10,000 | $13,500 | 0.01% |
| Ulland Investment Advisors, LLC | 0 | $0 | 0.00% |